Huynh Kevin, Abdeen Yazan
Medical School, College of Osteopathic Medicine, Sam Houston State University, Houston, USA.
Pulmonary and Critical Care Medicine, Pulmonary and Sleep Physicians of Houston, Webster, USA.
Cureus. 2023 May 10;15(5):e38858. doi: 10.7759/cureus.38858. eCollection 2023 May.
is a critically emerging cause of ventilator-associated pneumonia (VAP). is an oxidase-positive, nonfermenting, hydrogen-sulfide-producing, gram-negative bacillus. Worldwide, there have been six reported cases of pneumonia and two reported cases of VAP, both caused by . In this study, we discuss the case of a 59-year-old male who presented to the emergency department with altered mental status and acute respiratory distress. He was intubated for airway protection. Eight days following intubation, the patient developed symptoms consistent with VAP, and bronchoalveolar lavage (BAL) revealed , an emerging nosocomial and opportunistic pathogen, as the causative agent. The patient was treated with cefepime with the resolution of symptoms.
是呼吸机相关性肺炎（VAP）的一个关键新兴病因。是一种氧化酶阳性、不发酵、产硫化氢的革兰氏阴性杆菌。在全球范围内，已有6例由该菌引起的肺炎报告病例和2例由该菌引起的VAP报告病例。在本研究中，我们讨论了一名59岁男性的病例，该患者因精神状态改变和急性呼吸窘迫就诊于急诊科。为保护气道进行了插管。插管8天后，患者出现了与VAP一致的症状，支气管肺泡灌洗（BAL）显示该新兴的医院内感染和机会性病原体为病原体。患者接受头孢吡肟治疗后症状缓解。
